The best IRA CD rates offer guaranteed returns, making them an attractive option for savers who want a low-risk and steady way to grow their savings. If you’re looking for the best IRA CD rates ...

Every year, complaints come from the usual suspects demanding to know when Apple will innovate, and specifically when it will ...

Where you park your funds determines how much interest you’ll earn. We outline the best CD rates in Wisconsin to help you maximize your money, along with information on how much you can earn ...

Less than 48 hours before the arrival of Tyler, the Creator’s new album Chromakopia, the rapper has shared another preview with the video for “Thought I Was Dead.” As Tyler previously ...

CDs are also enjoying a resurgence for the first time in nearly 20 years. According to data from the Recording Industry Association of America (RIAA), CD sales rose by 11 per cent to $537 million in ...

Steven is a personal finance writer covering topics from mortgages to credit cards to market news. He has written for The Motley Fool Canada, Ramsey Solutions, Nerdwallet, Clever Real Estate, and ...

CD rates move in tandem with the federal funds rate, the benchmark interest rate set by the Federal Reserve. Yields on CDs rose above 10% in the early 1980s when the Fed set interest rates well ...

What about CD, then — the last physical form of media to grace record store shelves? Revo is relaunching its SuperCD music streaming all-in-one with a bunch of modern smart features, all in an ...

French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.

The firm, CD&R, is attempting to acquire control of Sanofi subsidiary Opella, which manufactures over-the-counter drugs like paracetamol. Sanofi announced on Monday that it had entered exclusive talks ...

The renewed negotiations come after CD&R agreed to pledges around local ... over a French rival as the frontrunner to acquire the maker of Doliprane painkiller earlier this month.

"Our demands on employment, production and investment will be respected," Armand said on X, apparently authorizing the sale of Sanofi's over-the-counter drug unit Opella to US investment fund CD&R.